Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Infection and Immunity|August 26, 1998
Partially protective vaccination permits the development of latency in a normally virulent strain of Toxoplasma gondiiG S Yap, T Scharton-Kersten, D J Ferguson, et al.Advanced Drug Delivery Reviews|September 1, 2000
Transcutaneous immunization of domestic animals: opportunities and challengesS A Hammond, C Tsonis, K Sellins, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 6, 1998
Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challengeG M Glenn, T Scharton-Kersten, R Vassell, et al.The Journal of Experimental Medicine|January 7, 1998
In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areasC Reis e Sousa, S Hieny, T Scharton-Kersten, et al.Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|August 1, 1998
Cytokines as determinants of disease and disease interactionsA Sher, R T Gazzinelli, D Jankovic, et al.Human Gene Therapy|September 19, 1998
Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasisP S Walker, T Scharton-Kersten, E D Rowton, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1997
Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondiiE Y Denkers, G Yap, T Scharton-Kersten, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1996
In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alphaR T Gazzinelli, M Wysocka, S Hieny, et al.Proceedings of the National Academy of Sciences of the United States of America|June 9, 1999
Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanismsP S Walker, T Scharton-Kersten, A M Krieg, et al.European Journal of Immunology|June 30, 1998
Failure of P strain mice to respond to vaccination against schistosomiasis correlates with impaired production of IL-12 and up-regulation of Th2 cytokines that inhibit macrophage activationI P Oswald, P Caspar, T A Wynn, et al.Pageof 3